{"id":"https://genegraph.clinicalgenome.org/r/c37eda0a-57be-49fa-a659-cbab971c4aabv2.0","type":"EvidenceStrengthAssertion","dc:description":"*PRICKLE1* was first reported in relation to autosomal recessive progressive myoclonic epilepsy (PME) in 2008 when Bassuk et al. studied 3 large consanguineous Middle Eastern pedigrees with autosomal recessive PME without variants in *CSTB*, another gene associated with Unverricht-Lundborg syndrome (PMID: 18976727). These families were all found to have an identical homozygous p.Arg104Gln variant. Later in 2018, Mastrangelo M et al. identified another proband with a similar phenotypic presentation and the homozygous p.Ala274Thr variant (PMID: 30345727). Additional probands were identified in the literature; however, they were not scored based on atypical phenotypes not consistent with PME and the high minor allele frequency of the variants detected (PMID: 30564977, 37593999). Per criteria outlined by the ClinGen Lumping and Splitting guidelines, we found a difference in inheritance pattern and phenotypic variability. Therefore, the following disease entities have been split into two disease entities: autosomal recessive progressive myoclonic epilepsy (PME) and autosomal dominant epilepsy. The split curation for autosomal dominant epilepsy has been curated separately. Experimental evidence identified in the literature was not scored as it did not provide sufficient evidence supporting the gene-disease relationship. \n\nIn summary, there is limited evidence to support the relationship between *PRICKLE1* and autosomal recessive progressive myoclonus epilepsy (PME). This classification was approved by the ClinGen Epilepsy GCEP on the meeting date July 1, 2025 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/c37eda0a-57be-49fa-a659-cbab971c4aab","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d4e1195f-21ea-4721-b94b-99604e7c6554","calculatedEvidenceStrength":"Limited","changes":[{"id":"cg:sopChange"},{"id":"cg:newEvidence"},{"id":"cg:summaryChange"},{"id":"cg:otherTextChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d4e1195f-21ea-4721-b94b-99604e7c6554_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2025-09-30T19:55:50.592Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/d4e1195f-21ea-4721-b94b-99604e7c6554_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2025-07-01T16:00:00.000Z","role":"Approver"}],"curationReasonDescription":"The ClinGen Epilepsy Gene Curation Expert Panel has classified this gene-disease relationship as Limited due to a lack of additional variants and recent publications.","curationReasons":["RecurationTiming"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4e1195f-21ea-4721-b94b-99604e7c6554_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ab0c33c-da8e-45cb-9d81-f464fc4656ac_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ab0c33c-da8e-45cb-9d81-f464fc4656ac","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15634728","rdfs:label":"VI-5","allele":{"id":"https://genegraph.clinicalgenome.org/r/15341fec-8c97-4f3c-a810-ea07850a35b1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153026.3(PRICKLE1):c.311G>A (p.Arg104Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339960"}},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0001251","obo:HP_0032794","obo:HP_0001336"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c32f62c4-d0ed-498d-ae1c-849b73067fee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15634728","allele":{"id":"https://genegraph.clinicalgenome.org/r/15341fec-8c97-4f3c-a810-ea07850a35b1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/c32f62c4-d0ed-498d-ae1c-849b73067fee","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c32f62c4-d0ed-498d-ae1c-849b73067fee_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c32f62c4-d0ed-498d-ae1c-849b73067fee_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The identified PRICKLE1 mutation disrupts both normal REST-binding and REST subcellular\nlocalization​","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/a6b25f0f-0b6f-4d09-83f3-9d3f5bac3692_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6b25f0f-0b6f-4d09-83f3-9d3f5bac3692","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16376507","rdfs:label":"V-3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"allele":{"id":"https://genegraph.clinicalgenome.org/r/15341fec-8c97-4f3c-a810-ea07850a35b1"},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0001350","obo:HP_0001251","obo:HP_0001337","obo:HP_0010819"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3976d817-e3a5-40c7-ad30-872af2bb12fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16376507","allele":{"id":"https://genegraph.clinicalgenome.org/r/15341fec-8c97-4f3c-a810-ea07850a35b1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/3976d817-e3a5-40c7-ad30-872af2bb12fc","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3976d817-e3a5-40c7-ad30-872af2bb12fc_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3976d817-e3a5-40c7-ad30-872af2bb12fc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The identified PRICKLE1 mutation disrupts both normal REST-binding and REST subcellular\nlocalization​","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/d4e1195f-21ea-4721-b94b-99604e7c6554_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96a366b2-e1cb-49c2-a750-e26825aa89b7_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15642921","rdfs:label":"Family C","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/96a366b2-e1cb-49c2-a750-e26825aa89b7","type":"Family","rdfs:label":"Family C"},"meetsInclusionCriteria":false,"phenotype":[{"id":"obo:HP_0001260"},{"id":"obo:HP_0001350"},{"id":"obo:HP_0020036"},{"id":"obo:HP_0025331"},{"id":"obo:HP_0001251"},{"id":"obo:HP_0032660"},{"id":"obo:HP_0002075"}],"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2},{"id":"https://genegraph.clinicalgenome.org/r/1c7a3484-a618-416c-ab3d-d981241f54a8_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18976727","rdfs:label":"Bassuk Family A","estimatedLodScore":5.71,"family":{"id":"https://genegraph.clinicalgenome.org/r/1c7a3484-a618-416c-ab3d-d981241f54a8","type":"Family","rdfs:label":"Bassuk Family A"},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":12,"phenotypePositiveAllelePositive":8,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/0cb08cee-21d7-4c83-a5c7-2b97b33eb961_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15634728","rdfs:label":"Family 1","family":{"id":"https://genegraph.clinicalgenome.org/r/0cb08cee-21d7-4c83-a5c7-2b97b33eb961","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/2ab0c33c-da8e-45cb-9d81-f464fc4656ac"}},"phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0001251","obo:HP_0001336","obo:HP_0032794"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2ab0c33c-da8e-45cb-9d81-f464fc4656ac"},"publishedLodScore":6.32,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e4cd6a70-8b4e-4807-b2b5-07a9e338380b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16376507","rdfs:label":"Family B","estimatedLodScore":6.02,"family":{"id":"https://genegraph.clinicalgenome.org/r/e4cd6a70-8b4e-4807-b2b5-07a9e338380b","type":"Family","rdfs:label":"Family B","member":{"id":"https://genegraph.clinicalgenome.org/r/a6b25f0f-0b6f-4d09-83f3-9d3f5bac3692"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":11,"phenotypes":["obo:HP_0001251","obo:HP_0001337","obo:HP_0001350","obo:HP_0010819"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a6b25f0f-0b6f-4d09-83f3-9d3f5bac3692"},"publishedLodScore":3.3,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/ae0daa00-0fed-4614-91e1-aeffa06f2760_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae0daa00-0fed-4614-91e1-aeffa06f2760","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30564977","rdfs:label":"II-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":23,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/2263b419-ff01-462d-9254-d066e39ea810","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153026.3(PRICKLE1):c.2278_2280del (p.Asp760del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6519626"}},{"id":"https://genegraph.clinicalgenome.org/r/13e5e943-5ef5-43f2-ac35-189f4e45f7b9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153026.3(PRICKLE1):c.601G>A (p.Asp201Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384443604"}}],"detectionMethod":"Next-generation sequencing (NGS) of 146 epilepsy-related genes and 73 inherited cardiac disease-related genes was performed","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Male with sudden loss of consciousness with convulsions, coma, and death. No reported clinical features of PME. ","previousTesting":false,"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/affe9796-126b-4509-a32c-44909317aeed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30564977","allele":{"id":"https://genegraph.clinicalgenome.org/r/2263b419-ff01-462d-9254-d066e39ea810"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/3efe9199-f65e-464b-8a12-3cf2783336a1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30564977","allele":{"id":"https://genegraph.clinicalgenome.org/r/13e5e943-5ef5-43f2-ac35-189f4e45f7b9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/affe9796-126b-4509-a32c-44909317aeed","type":"EvidenceLine","dc:description":"Do not score based on atypical phenotype and variant minor allele frequency (3 homozygotes in gnomAD v4).","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/affe9796-126b-4509-a32c-44909317aeed_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3efe9199-f65e-464b-8a12-3cf2783336a1","type":"EvidenceLine","dc:description":"Do not score based on atypical phenotype and one of two variants detected has a high minor allele frequency.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3efe9199-f65e-464b-8a12-3cf2783336a1_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5726ac16-c95e-4fae-b6a2-d0251d487d48_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5726ac16-c95e-4fae-b6a2-d0251d487d48","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30345727","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8713e3ca-c4dd-4021-8066-c099688f26bd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153026.3(PRICKLE1):c.820G>A (p.Ala274Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6519824"}},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Myoclonic jerks, seizures, developmental delay, ataxia.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/478e41b8-2e2c-4283-8896-f2e3ba86abb2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30345727","allele":{"id":"https://genegraph.clinicalgenome.org/r/8713e3ca-c4dd-4021-8066-c099688f26bd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/478e41b8-2e2c-4283-8896-f2e3ba86abb2","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/478e41b8-2e2c-4283-8896-f2e3ba86abb2_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/bca60c1a-fb56-4244-9628-75ed840f9f69_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bca60c1a-fb56-4244-9628-75ed840f9f69","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37593999","rdfs:label":"23","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/5d0f77b6-4944-495d-b3f6-c3d1a1e203f5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153026.3(PRICKLE1):c.1903G>A (p.Asp635Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384440637"}},{"id":"https://genegraph.clinicalgenome.org/r/18305daf-d26f-4acf-bb31-80b6a6ca75b4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153026.3(PRICKLE1):c.113C>T (p.Pro38Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA316968"}}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Repetitive seizures in NREM sleep: multifocal slow wave, sharp slow wave, and slow spike–wave mainly occur in the bilateral Rolandic regions; bronchopneumonia and hepatosplenomegaly.","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/cd087306-3f39-418b-bd0b-281a93a0c46e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37593999","allele":{"id":"https://genegraph.clinicalgenome.org/r/18305daf-d26f-4acf-bb31-80b6a6ca75b4"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/f7b1975a-7c93-4f05-99fd-5fdba6a52763_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37593999","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d0f77b6-4944-495d-b3f6-c3d1a1e203f5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/f7b1975a-7c93-4f05-99fd-5fdba6a52763","type":"EvidenceLine","dc:description":"Do not score based on atypical phenotype and one of two detected variants has high minor allele frequency. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7b1975a-7c93-4f05-99fd-5fdba6a52763_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cd087306-3f39-418b-bd0b-281a93a0c46e","type":"EvidenceLine","dc:description":"Do not score based on atypical phenotype and high minor allele frequency (4 homozygotes in gnomAD v4).","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd087306-3f39-418b-bd0b-281a93a0c46e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":5.2},{"id":"https://genegraph.clinicalgenome.org/r/d4e1195f-21ea-4721-b94b-99604e7c6554_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4e1195f-21ea-4721-b94b-99604e7c6554_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/570ddde6-3219-4152-995e-97983177443a","type":"EvidenceLine","dc:description":"The Epilepsy GCEP no longer scores expression data as this does not provide direct evidence of epilepsy causation. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4df14c44-3af6-4415-8fe8-72d12ce3cf41","type":"Finding","dc:description":"Mouse Prickle1 and Prickle2 are continually expressed in the brain throughout the embryonic stages and are observed to be specifically expressed in the postmitotic neurons. Mouse Pk1 transcripts are detected in the subplate and cortical plate at E17.5, when majority of cortical neurons are undergoing maturation. Pk1 is also expressed in other brain areas such as hippocampus and non-neural tissues as well such as lens.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17868671","rdfs:label":"Mouse Prickle1 expressed in postmitotic neurons","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/30fc120d-eff7-4f44-9dc8-9b3845c5a0b7","type":"EvidenceLine","dc:description":"The Epilepsy GCEP no longer scores expression data as this does not provide direct evidence of epilepsy causation. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/257e0ea3-1e79-4451-b672-d94e4280afbd","type":"Finding","dc:description":"Prickle1 expression was observed in murine thalamus, hippocampus, cerebral cortex and cerebellum– areas of the brain thought to be involved in generating zeizures and ataxia. Co-staining these tissues with a neuron-specific marker NeuN and the glia-specific marker GFAP showed Prickles in specifically expressed in neurons but not in glia.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18976727","rdfs:label":"Prickle1 expression in the postnatal murine brain","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d4e1195f-21ea-4721-b94b-99604e7c6554_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c05bf111-2ddd-4c46-80ed-7974491d2c03","type":"EvidenceLine","dc:description":"Used to score proband in whom the variant was identified","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d41c13b-d498-4668-811a-2f86a3b39a35","type":"FunctionalAlteration","dc:description":"There was a significant increase of nuclear REST in cells cotransfected with mutant PRICKLE1. Therefore, the identified PRICKLE1 mutation disrupts both normal REST-binding and REST subcellular localization.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18976727","rdfs:label":"PRICKLE1 binding to REST/NRSF"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/14ac3707-24cc-478a-87f4-66bbf063cbb0","type":"EvidenceLine","dc:description":"Decreased neurite outgrowth does not provide a direct relationship to seizure etiology.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a4846e1-52bc-4138-a608-a99cc2f6c69f","type":"FunctionalAlteration","dc:description":"Prickle1 depletion effectively decreases the neurite outgrowth levels of mouse neuroblastoma Neuro2a cells. These results indicate that mouse Prickle1 possibly regulate positive neurite formation during brain development.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17868671","rdfs:label":"Decrease in neurite outgrowth levels of mouse neuroblastoma"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d4e1195f-21ea-4721-b94b-99604e7c6554_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55319789-7fcf-4085-865f-6dbb7558fb4b","type":"EvidenceLine","dc:description":"Human phenotype not recapitulated in homozygous mice. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de305ed3-a0a4-4f92-9dcd-b59c2060dace","type":"Finding","dc:description":"Homozygous mice did not recapitulate human PME phenotype.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34597683","rdfs:label":"Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d4a4da6b-02fd-42c4-84f9-94c0cfc28e84","type":"EvidenceLine","dc:description":"Inconsistent zygosity with disease mechanism. Prickle1 -/- embryos were not viable.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5730a697-3794-4626-a3e0-571ba9893c79","type":"Finding","dc:description":"Seizure threshold was tested via the maximal electroconvulsive seizure threshold (MEST) test, which scores the occurrence of tonic hind- limb seizures at a specific amperage of applied electrical shock. Prickle1+/-, mice displayed a decreased seizure threshold compared to that of wild- type littermates. \nPrickle1 -/+ mutants produced a seizure phenotype which was controlled by administering Valproic Acid, a drug used to treat patients scored in this curation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21276947","rdfs:label":"Decreased Seizure Threshold in Mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cedcddbb-975d-49b3-82ce-8d837100cb40","type":"EvidenceLine","dc:description":"The phenotype observed does not match those of patients with PME.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b58809e5-2fb1-4884-b472-944237bccd48","type":"Finding","dc:description":"These phenotypes do not match and therefore the study was not scored.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12874125","rdfs:label":"Cell movement regulation in zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1626e141-6d64-43c7-b341-d1725c459940","type":"EvidenceLine","dc:description":"This model doesn't recapitulate PME phenotype","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb10aa25-6900-4f25-b85d-73b611c1fea2","type":"Finding","dc:description":"The phenotype does not match those of patients with PME","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18976727","rdfs:label":"R104Q mutant zebrafish model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/49beaf77-9bd3-45aa-a215-259f1f478cd0","type":"EvidenceLine","dc:description":"Did not score as it is unclear if drosophila phenotype truly represents seizures.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/154a4fc8-d8dc-474b-be73-61c878bcf261","type":"Finding","dc:description":"In the absence of external stimulation, pkIG1-1mutant flies occasionally exhibited convulsive leaping or rolling, and sometimes even paralysis. ​Collectively, pkIG1-1 represents a new pk mutant fly strain, which showed low expression of both isoforms (pk and sple) and high incidence of spontaneous seizures​. Homozygous pkIG1-1 mutant larvae, 33.3% of the ddaE neurons showed\nincomplete glial wrapping, higher than the rate found in either heterozygous pkIG1-1/+ larvae (12.5%, Figures 3B and 3C) or wild-type larvae.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36582832","rdfs:label":"Gal4 Fly Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a76a750a-6f40-4fc0-bbe0-6b5ea5faee17","type":"EvidenceLine","dc:description":"Did not score as it is unclear if the drosophila behaviors truly represent seizures. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7331b7b2-fef6-4115-bad4-5aff270d85ed","type":"Finding","dc:description":"Drosophila phenotype suggested to represent spontaneous muscle-jerk seizures and ataxia. Seizure‐prone pk sple homozygotes showed a significant increase in the percent of flipping flies per vial (P < 0.0001; Fig. 1A), which assesses muscle‐jerk seizure activity. A significant proportion of the pk sple homozygotes exhibited pronounced spontaneous muscle‐jerk seizures. ​ Only the pk sple homozygotes showed reductions in synchronous movement compared to the other genotypes, (Fig. 4A,B; compare Movies 3, 4 and 5), demonstrating that these flies were indeed ataxic.​ \"These results document for the first time spontaneous, unprovoked seizure events at high resolution in a fly human seizure disorder model, capturing seizures in their native state.\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27648459","rdfs:label":"Drosophila Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0}],"evidenceStrength":"Limited","sequence":11891,"specifiedBy":"GeneValidityCriteria11","strengthScore":5.2,"subject":{"id":"https://genegraph.clinicalgenome.org/r/87sNJWEVH2o","type":"GeneValidityProposition","disease":"obo:MONDO_0020074","gene":"hgnc:17019","modeOfInheritance":"obo:HP_0000007"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d4e1195f-21ea-4721-b94b-99604e7c6554-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}